INTRODUCTION
Nucleic acid extraction is one of the most basic requirements in a molecular biology laboratory. The diverse nucleic acid extraction protocols by and large fall into one of three categories: (i) the classic extraction methods; (ii) unmodified silica resin-dependent protocols; and (iii) commercial column-based strategies. The classic alkaline lysis method (1) and the phenol chloroform extraction strategy (2) are highly popular, as they are the least expensive and do not require sophisticated equipment. These protocols, however, are associated with serious practical limitations, including the quality of the DNA extracted and the time required for processing a large number of samples. Furthermore, these procedures are not preferred for amplification-based clinical diagnosis, considering the impending risk of contamination (3, 4) . A wide variety of protocols have been developed using native unmodified silica resin (5) (6) (7) (8) (9) (10) (11) or its derivatives, such as diatomaceous earth (12) or pumice (13) for preferential isolation of nucleic acids. Although the quality and quantity of the nucleic acids extracted using the crude silica are superior to the conventional techniques, they are certainly not suitable for a range of applications, such as in vitro transcription/translation, microinjection, and immunization (8) . When purity of the nucleic acids is an important consideration, commercial nucleic acid extraction columns have no substitute. A variety of commercial nucleic acid extraction columns available from several vendors by and large use a similar strategy to purify nucleic acids by exploiting the negative charge of the phosphate backbone. Many of the commercial nucleic acid extraction columns are essentially silica-based; however, the silica resin or membranes are chemically modified by attaching strong anionic groups such as the diethylaminoethyl (DEAE) moiety.
The high surface density of the anion groups on such chemically modified silica resins makes the resins efficient and highly selective for nucleic acids in the presence of high salt concentration and pH conditions. Commercial nucleic acid extraction columns, therefore, ensure the highest level of nucleic acid recovery and purity with little technical complication. Commercial nucleic acid extraction columns, however, are expensive and are disposed of after a single use. Considering the cost factor, we set out to develop a procedure to regenerate the commercial nucleic acid extraction columns. We found that incubation of used commercial nucleic acid extraction columns in 1 M HCl for 24 h can efficiently eliminate bound DNA and regenerate them for a fresh round of use. Applying this strategy, the commercial nucleic acid extraction columns can be regenerated many times without a loss in the binding capacity and, importantly, without the possibility of carryover contamination.
MATERIALS AND METHODS

Regeneration of the Commercial Columns
Commercial nucleic acid extraction columns after one round of use were stored in 1 M HCl for a specified period or indefinitely. Before use, the columns were removed from the acid, rinsed thoroughly in sterile distilled water, and equilibrated with Buffer QBT (Qiagen, Valencia, CA, USA) or an equivalent. The volume of water and buffer used to wash the columns typically depended on the nature and the capacity of the columns. For Qiagen-tip 20 columns (Qiagen), for instance, we typically used 5 mL sterile distilled water per wash for five rounds and 5 mL Buffer QC (Qiagen) for one round to regenerate the columns.
Transfection of the Mammalian Cells and Reporter Gene Analysis
HEK 293 cells were transfected with plasmid expression vectors using a standard calcium phosphate method (14 
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were transfected with a total of 1.1 μg plasmid DNA, consisting of 1 μg reporter vector and 0.1 μg pCMV-β-galactosidase expression vector-the latter included in all the transfections to serve as an internal control for the transfection efficiency. CEM-GFP cells were electroporated using the Gene Pulser ® II system (Bio-Rad Laboratories, Hercules, CA, USA) at 240 V and 950 μF capacitance with a total of 5 μg DNA consisting of a mixture of 4 μg Tat-expression vector, pCMV Tat, and 1 μg cytomegalovirus (CMV)-β-galactosidase plasmid. Gene expression from the transfected cells was monitored starting from 24 h after transfection up to 72 h. Quantitation of the reporter genes, including the secreted alkaline phosphatase (SEAP), green fluorescent protein (GFP), β-galactosidase, and the viral antigen p24 was performed as described previously (15) .
Bacterial Transformation and PCR Amplification of the Plasmids
Two plasmids were used-one encoding the human immunodeficiency virus type-1 (HIV-1) Tat and the ampicillin resistance marker (pCMV-Tat-Amp R , 5728 bp) and the other containing the HIV-1 p24 and the kanamycin resistance marker (pCMVp24-Kan R , 4759 bp). Six fresh Qiagentip 20 columns were loaded with pCMV-p24-Kan R , washed, and eluted once with Buffer QF (Qiagen), thus leaving significant quantities of the residual Kan R plasmid on the columns. Three of the six columns were incubated in 1 M HCl for 4 h, while the others were incubated in Buffer QC. After the incubation, both the sets were extensively washed in Buffer QC and loaded with a second plasmid, pCMVTat-Amp R . The plasmid was eluted once, and the DNA concentration was determined spectrophotometrically. Chemical competent Escherichia coli cells were transformed with 1 ng plasmid preparations and seeded on LB agar plates supplemented with 50 μg/mL ampicillin or kanamycin. The number of colonies developed on the plates after a 16 h incubation at 37°C was manually determined. A nested PCR amplification strategy sensitive enough to detect single-copy template DNA (see Figure 3B ) was used to detect Tat or p24 encoded by the Amp R and Kan R plasmids, respectively. Plasmid preparations extracted above were diluted in 50 ng/μL salmon sperm DNA as carrier DNA, to contain 10,000 or 1000 input copies for the PCR. For positive standards, pCMV-Tat-Amp R and pCMV-p24-Kan R plasmids were subjected to a serial 10-fold dilution in carrier DNA. The amplified fragments were resolved on a 1% agarose gel and visualized by ethidium bromide staining.
Real-Time Reverse Transcription PCR for the HIV-1 Long Terminal Repeat
Total RNA was extracted from 150 μL HIV-1 seropositive plasma samples using two different commercial kits, Auprep ® PCR Purification columns (Life Technologies™; Invitrogen, Carlsbad, CA, USA) and Qiagen Viral RNA Mini kit columns, following the manufacturers' instructions. RNA bound to the columns was eluted in 50 μL RNasefree water, and half of this quantity was used in reverse transcription reaction 
Analysis of the Fate of the DNA Exposed to Acid
A plasmid pC-LTR-SIE was linearized and labeled with [α-32 P]dCTP in a standard random labeling reaction using the NEBlot ® kit (New England BioLabs, Ipswich, MA, USA) and purified on a G-50 Sephadex ® column. Labeled DNA was mixed with the same but unlabeled plasmid DNA at a 1:50 ratio for the assay. Six fresh spin columns were loaded each with 10 μg pulsed DNA and exposed to 200 μL 1 M HCl in a plastic vial in a way that the membrane is immersed in the acid. The column-bound DNA was treated for different periods ranging from 0 min to 24 h. At the end of the incubation, equal volume of 1 M Tris buffer, pH 11.5, was added to each column, mixed well, and the column was spun at full speed to collect the sample in the lower chamber. DNA was eluted from the columns and precipitated overnight at -20°C by adding 2 volumes of ethanol in the presence of 2 M ammonium acetate, pH 4.8. DNA pellet was dissolved in 50 μL Tris EDTA (TE), pH 8.0, normalized for the radioactivity counts, and resolved on a gradient polyacrylamide gel (6%-15%). The gel was wrapped in a plastic film, directly exposed to a phosphor imager plate, and analyzed on an FLA-5000 Phosphor Imager (Fuji, Osaka, Japan).
RESULTS AND DISCUSSION
Regeneration of the Commercial Columns
Previously we reported a strategy for small-scale plasmid DNA extraction using silica (8) . Preparation of the silica required incubation of the resin at a low pH to destroy resin-associated DNA. To see if silica used once can be 
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regenerated, we incubated used resin in 1 M HCl for 4 h and compared it with fresh resin for the extraction of plasmid DNA. Fresh and treated silica both isolated plasmid DNA at comparable levels ( Figure 1A) , suggesting that the DNA binding property of the resin was not acid-labile. We next extended this regeneration technique to Qiagen-tip 20 columns and identified that these columns could be regenerated in the same manner ( Figure  1B) . Following this observation, we set up several experiments to optimize regeneration of the commercial nucleic acid extraction columns from different suppliers. For consistency, bacterial cultures containing plasmid vectors were grown to large volumes, the cells were harvested, resuspended in Buffer P1 (Qiagen), and then stored in multiple aliquots in a deep freezer. Aliquots were removed as required and used for various experiments described below.
To identify the optimal concentration of HCl and the time of incubation needed to regenerate the columns, we loaded several fresh columns with plasmid DNA. Columns with DNA bound on them were incubated in 0.1 or 1.0 M HCl for different periods; the bound DNA was eluted with Buffer QF, and the DNA was resolved on a 1% agarose gel. Incubation of the columns in 0.1 M HCl required 48 h to completely eliminate the bound plasmid DNA from the columns, whereas no plasmid DNA was found on the columns after 4 h incubation in 1 M HCl ( Figure 1C ). Prolonged exposure of the columns to 1 M HCl for 0, 10, and 30 days or longer did not alter the DNA binding capacity of the columns, suggesting that the active groups on the resin surface are quite stable to acid exposure ( Figure 1D ). As illustrated, the columns can be regenerated many times without a reduction in the binding capacity ( Figure 1E ). In our experience, most of the columns could be regenerated up to 20 times. DNA eluted from each round was resolved on a 1% agarose gel to confirm the supercoiled nature of the plasmid ( Figure 1E , middle panel) and comparable expression levels of the encoded enhanced GFP (EGFP) ( Figure 1E,  bottom panel) . We applied the regeneration protocol to diverse columns from Qiagen that use different strategies of plasmid purification, spin versus gravity separation, or different scales of DNA yield (data not presented), as well as columns from different manufacturers ( Figure 1F ). Additionally, we tested columns intended for genomic DNA isolation (data not presented), extraction of DNA from agarose gels (data not presented), and RNA extraction (see section entitled Nucleic Acids Purified with Regenerated Columns Are Functionally Competent) and obtained similar results.
Nucleic Acids Purified with Regenerated Columns Are Functionally Competent
We observed comparable expression levels of different mammalian genes from plasmids prepared using fresh columns or columns regenerated for five rounds (Figure 2) . A plasmid vector pCMV-SEAP, encoding SEAP under the control of a CMV promoter, expressed comparable levels of SEAP when the plasmid was isolated with fresh or regenerated columns ( Figure  2A) . Identical results were obtained Regeneration process destroys the residual DNA. Two sets of columns were differentially treated to leave the contaminating plasmid (pCMV-p24-Kan R ) on one of the sets. A second plasmid (pCMV-TatAmp R ) was extracted using both the sets, and transformed bacteria were seeded on LB agar plates supplemented with ampicillin or kanamycin. The number of colonies developed on the plates was manually determined. This experiment was repeated three times, and the data presented are from one representative experiment. The data are presented as mean of triplicate assays ±1 sd (B) PCR-mediated detection of the contaminating plasmid DNA. Plasmid preparations extracted above were diluted to defined copy numbers in the presence of carrier DNA and used as a template in a nested PCR for the detection of Tat and p24 targets encoded by the Amp R and Kan R plasmids, respectively (right panels). For positive standards, the plasmids were subjected to a serial 10-fold dilution in the presence of carrier DNA to contain defined number of copies as shown (left panels). M, DNA molecular weight standards (GeneRuler 100-bp DNA ladder; Fermentas), and the standard sizes are indicated. (C) Acid-treated DNA is degraded on the column to low molecular weight fragments. Isotopically labeled plasmid DNA was loaded to the columns and exposed to 1 M HCl for different periods as shown. Eluted DNA normalized for the radioactivity counts was subjected to electrophoresis on a 6%-15% gradient polyacrylamide gel and analyzed by phosphor imager scanning. The experiment was repeated several times, and the data presented are representative of one such experiment. Oligonucleotides of known molecular size were end-labeled with [γ-32 P]dATP and used as molecular weight standards as shown. 
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with a GFP expression vector, pCMV-EGFP ( Figure 1E , bottom panel). The plasmid pINDIE harbors a full-length molecular clone of HIV-1. HEK 293 cells transfected with pINDIE secreted comparable levels of the viral core antigen p24 into the medium at 24, 48, and 72 h ( Figure 2B ). CEM-GFP cells electroporated with pCMV-Tat, prepared using fresh and regenerated columns, induced comparable levels of GFP expression as determined by flow cytometry ( Figure 2C ). We also regenerated commercial nucleic acid extraction columns for total RNA extraction from human plasma samples and evaluated the RNA quality in a real-time RT-PCR targeting the HIV-1 promoter sequence. Total RNA was extracted from 150-μL plasma of each of five individual HIV-1 seropositive donors using commercial nucleic acid extraction columns supplied by two different manufacturers. RNA extracted with fresh or regenerated columns amplified the target sequence in a manner indistinguishable from each other ( Figure 2D ). We did not see large differences in viral titers among the individual donors tested, probably as all the donors were drug-naïve and asymptomatic. However, the C T values of the samples of the highest and lowest titer differed by 4.5 cycles, suggesting a 20-to 25-fold difference in viral load between these donors.
Acid-Treated DNA Is Degraded to Small Fragments and Cannot Function as a Template
The most serious concern with the reuse of the disposable columns is the possibility of nucleic acid carryover from one preparation to the next. Even the minutest quantity of nucleic acid carryover between samples could have serious consequences for subsequent molecular manipulations. Therefore, it is critical to ensure that the columns are absolutely free of residual DNA after regeneration. We devised a series of experiments to detect residual DNA on the columns after regeneration. We selected a pair of vectors containing two different drug markers, ampicillin and kanamycin, for differential colony plating and two different gene sequences, p24 and Tat, for differential PCR amplification in the subsequent experiments.
Six fresh Qiagen-tip 20 columns were loaded with a plasmid DNA containing the kanamycin-resistance gene (pCMVp24-Kan R ). After washing, the columns were eluted only once, thus leaving a significant quantity of the residual Kan R plasmid on the columns, which was expected to be approximately 5-6 μg or 20% of the overall binding capacity of the column (see Figure 1D) . Three of the six columns were incubated in 1 M HCl for 4 h to strip the residual DNA. The other three columns were incubated in Buffer QC and were expected to contain residual plasmid DNA that should be carried over to the next round of purification. After the incubation, both sets of the columns were washed and loaded with a second plasmid containing the ampicillin-resistance gene (pCMVTat-Amp R ). Bound plasmid was eluted from the columns, and competent E. coli cells were transformed and seeded on agarose plates supplemented with ampicillin or kanamycin. The number of colonies developed on the plates after a 16 h incubation was determined. Amp R plasmid extracted using the regenerated column contained approximately 400 colonies on the ampicillin plate and absolutely no colonies on the kanamycin plate ( Figure 3A) . In contrast, plasmid DNA extracted using the contaminated columns contained approximately 300 and 20 colonies on plates supplemented with ampicillin and kanamycin, respectively. To validate this finding, we used PCR to detect the presence of residual DNA in the plasmid preparation. We optimized PCRs for Tat (Amp R , 240 bp) and p24 (Kan R , 330 bp) to detect target genes on respective plasmids. Both the PCRs were sensitive enough to detect a single copy of the template ( Figure 3B , left panels). The Tat PCR successfully amplified the target DNA from both the plasmid preparations as expected ( Figure 3B, top panel) . In contrast, p24 PCR-amplified only the DNA isolated with the reused, but not the regenerated columns ( Figure 3B, lower panel) . Furthermore, we examined the fate of the DNA exposed to 1 M HCl while bound on the column. Radioactively labeled DNA bound on the columns was exposed to 1 M HCl for different time periods, recovered, and analyzed as described in the Materials and Methods section. We observed a progressive degradation of the DNA with prolonged exposure to HCl ( Figure 3C ). At zero time point, most of the DNA remained in the well, and DNA that entered the gel developed a smear in the lane. DNA exposed to acid for periods as short as 60 min readily entered the gel and migrated below the 36-bp marker. After 24 h, nearly all the DNA moved into the gel and was predominantly reduced to a size below 36 bp. The data presented in Figure 3 collectively proved that DNA exposed to 1 M HCl was efficiently destroyed, and the columns regenerated thus were safe for reuse without a risk of carryover contamination.
In summary, we identified an efficient, simple, and inexpensive procedure to regenerate commercial nucleic acid extraction columns. Commercial kits supply limited volume of the buffers required for column regeneration. However, the composition of the buffers is provided in several technical brochures, and a laboratory with adequate molecular biology expertise should be able to make its own reagents. We routinely store the columns in 1 M HCl, as this procedure not only regenerates the columns but also prevents microbial growth. A procedure to permit safe and efficient regeneration of the commercial columns makes them commercially more affordable, especially in a resource-poor setting.
